Literature DB >> 2117155

The role of eosinophils in asthma.

C Kroegel1.   

Abstract

During recent years it has become apparent that the eosinophil may represent a powerful effector cell in the pathogenesis of asthma, particularly in the late asthmatic response. It can be stimulated by a number of stimuli among which PAF appears to be one of the most effective. The eosinophil is a source for a variety of proinflammatory and toxic products with profound effect in the lungs and airways. These eosinophil products mimic some of the features of asthma and the strong association of the eosinophil with asthma has led to the suggestion that asthma would be better classified as "chronic desquamating eosinophilic bronchitis." Although the evidence known to date is persuasive many questions still remain unanswered and await further investigation. Future therapeutic approaches in asthma may aim at interrupting the mechanisms leading to eosinophil bronchial accumulation and activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117155     DOI: 10.1007/bf02718107

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  76 in total

1.  Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro.

Authors:  G Marone; A Kagey-Sobotka; L M Lichtenstein
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

Review 2.  Neuropeptides in the lung: localization, function, and pathophysiologic implications.

Authors:  P J Barnes
Journal:  J Allergy Clin Immunol       Date:  1987-02       Impact factor: 10.793

3.  Airway permeability to horseradish peroxidase in guinea pigs: the repair phase after injury by cigarette smoke.

Authors:  W C Hulbert; D C Walker; A Jackson; J C Hogg
Journal:  Am Rev Respir Dis       Date:  1981-03

4.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

5.  Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils.

Authors:  C Kroegel; T Yukawa; J Westwick; P J Barnes
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

6.  Increased biosynthesis of platelet-activating factor in activated human eosinophils.

Authors:  T Lee; D J Lenihan; B Malone; L L Roddy; S I Wasserman
Journal:  J Biol Chem       Date:  1984-05-10       Impact factor: 5.157

7.  Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement.

Authors:  P Diaz; F R Galleguillos; M C Gonzalez; C F Pantin; A B Kay
Journal:  J Allergy Clin Immunol       Date:  1984-07       Impact factor: 10.793

8.  Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man.

Authors:  C B Archer; C P Page; J Morley; D M MacDonald
Journal:  Br J Dermatol       Date:  1985-03       Impact factor: 9.302

9.  Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.

Authors:  A Lellouch-Tubiana; J Lefort; M T Simon; A Pfister; B B Vargaftig
Journal:  Am Rev Respir Dis       Date:  1988-04

10.  Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma.

Authors:  E Frigas; D A Loegering; G O Solley; G M Farrow; G J Gleich
Journal:  Mayo Clin Proc       Date:  1981-06       Impact factor: 7.616

View more
  5 in total

1.  Selective inflammatory response induced by intratracheal and intravenous administration of poly-L-arginine in guinea pig lungs.

Authors:  D Arseneault; K Maghni; P Sirois
Journal:  Inflammation       Date:  1999-06       Impact factor: 4.092

2.  Morphology and density features of eosinophil leukocytes in eosinophilic pneumonia. A case report.

Authors:  C Kroegel; H Matthys; U Costabel
Journal:  Clin Investig       Date:  1992-05

Review 3.  Future developments in the pharmacotherapy of lung disease.

Authors:  A Van der Kuy
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

4.  IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils.

Authors:  L A Bober; T A Waters; C C Pugliese-Sivo; L M Sullivan; S K Narula; M J Grace
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

5.  p-STAT6, PU.1, and NF-κB are involved in allergen-induced late-phase airway inflammation in asthma patients.

Authors:  Deimante Hoppenot; Kestutis Malakauskas; Simona Lavinskiene; Raimundas Sakalauskas
Journal:  BMC Pulm Med       Date:  2015-10-14       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.